Galderma Signed Exclusive Negotiation Agreement with Truinject
- Disclosed value
- $75,000
- From transcript
- Document date
- Oct 1, 2026
The 30-second brief
Galderma S.A. entered into a 90-day Exclusive Negotiation Agreement with Truinject Corp. in November 2014 and paid Truinject $75,000. The agreement covered potential partnership discussions involving Truinject’s Kate dermal-injection training system, but the discussions ended without a deal.
Galderma S.A. holds this contract with U.S. Court of Appeals for the Federal Circuit.
Term as filed: 90-day exclusivity period beginning November 5, 2014 and ending in early February 2015; confidentiality restriction continued for three years after the exclusivity period; Galderma restrictions on substantially similar products continued for nine months from November 5, 2014, ending in early August 2015.
See who decides the next one before it's bid.
Get pre-RFPs freeFree account · 30-second setup · No credit card
Contract details
- Amount
- $75,000
- Document date
- October 1, 2026
- Term
- 90-day exclusivity period beginning November 5, 2014 and ending in early February 2015; confidentiality restriction continued for three years after the exclusivity period; Galderma restrictions on substantially similar products continued for nine months from November 5, 2014, ending in early August 2015
- Vendor
- Galderma S.A.
- Source document
- United States Court of Appeals for the Federal Circuit Transcript Truinject Corp. v. Galderma S.A. 2026-10-01 (Transcript)
Galderma S.A.'s other public contracts
More U.S. Court of Appeals for the Federal Circuit contracts
Questions about this contract
Who was awarded the government contract by U.S. Court of Appeals for the Federal Circuit?
Galderma S.A. was awarded this government contract by U.S. Court of Appeals for the Federal Circuit, as recorded on October 1, 2026. The contract value is $75,000.
How much is the Galderma S.A. contract with U.S. Court of Appeals for the Federal Circuit worth?
The Galderma S.A. contract with U.S. Court of Appeals for the Federal Circuit is valued at $75,000.
What type of contract is this?
This is a government contract, documented as a transcript record.
Where was this contract approved?
This contract appears in United States Court of Appeals for the Federal Circuit Transcript Truinject Corp. v. Galderma S.A. 2026-10-01 (Transcript), dated October 1, 2026 from U.S. Court of Appeals for the Federal Circuit. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
Show 1 more question
What is U.S. Court of Appeals for the Federal Circuit currently buying?
Explore U.S. Court of Appeals for the Federal Circuit's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.